The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...
LOTTE BIOLOGICS (CEO James Park) announced on January 16 that it had presented at the "Asia-Pacific (APAC)" track of the J.P.
GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
Reminders of the killing of UnitedHealthcare CEO Brian Thompson were everywhere at this year's J.P. Morgan conference.
At the JP Morgan Conference 2025, CEO Chen said the potential of the Biosecure Act passing has had only a minimal chilling ...
Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.
Medicare Advantage (MA) insurers Alignment Healthcare and Clover Health both reported increased membership growth ahead of ...
The current head of the Center for Medicare has advice for her successor: "Engaging everyone in the ecosystem" is the ...
After several years in the doldrums, pharmaceutical companies and biotechs expect an uptick in dealmaking in 2025, with some ...
It was an extremely busy week in the biotech sector, with several companies making important presentations at the J.P. Morgan ...
Healthcare & Pharmaceuticalscategory Novartis wins temporary pause to Entresto generic launch in US 2:11 AM UTC Legalcategory Gilead Sciences, US government settle patent case over HIV prevention ...
Highlights from the third day included information about Quanterix's new SIMOA One platform, expected to launch at the end of ...